International Registry for Primary Hyperoxaluria

Status Withdrawn

Clinical Trial Summary

The purpose of this study is to collect medical information from a large number of patients in many areas of the world with primary hyperoxaluria. This medical information will be entered into a registry to help the investigators compare similarities and differences in patients and their symptoms. The more patients that the investigators are able to enter into the registry, the more the investigators will be able to understand primary hyperoxaluria and learn better ways of treating patients with this disease. It is the investigators hope that by entering as many patients with PH as possible, the information that the investigators collect may help physicians diagnose patients sooner and determine what treatments may work best on patients with similar medical or genetic backgrounds.

Clinical Trial Description

This study involves the collection of medical information to create a computer database (registry) for patients with PH. The information will be entered into the registry by your physician, healthcare provider or a staff member of the Mayo Clinic Hyperoxaluria Center. The computer web site for the registry is secure and protected by a required password. Some information which will be entered may include your age at first symptoms of PH,kidney stone history, lab values, kidney function, and your health over time. Information for a patient can only be viewed by the appropriate physician and staff. Once the information is entered into the registry, you will only be identified by a code number. ;

Study Design

Observational Model: Cohort, Time Perspective: Retrospective

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00875823
Study type	Observational
Source	Mayo Clinic
Contact
Status	Withdrawn
Phase	N/A
Start date	September 2003
Completion date	July 2009

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02547805` - Evaluate the Effect of ALLN-177 in Reducing Urinary Oxalate in Patients With Secondary Hyperoxaluria and Kidney Stones Over 28 Days	Phase 2
Completed	`NCT02579161` - Trial of Randomized Antibiotic Administration in Percutaneous Nephrolithotomy	Phase 3
Completed	`NCT01187745` - Study to Look for Artifact on Computed Tomography (CT) Representing Kidney Stones	N/A
Completed	`NCT05519150` - Donors With Nephrolithiasis at the Time of Transplant Evaluation (DONATE). Long Term Follow-up.
Recruiting	`NCT02522689` - Comparison of Ultra-mini PCNL and Micro PCNL	N/A
Recruiting	`NCT01514032` - Extracorporal Shockwave Lithotripsy Versus Retrograde Intrarenal Surgery for the Treatment of Kidney Stones	N/A
Completed	`NCT00765128` - Intravenous Ketorolac for Postoperative Pain in Percutaneous Nephrolithotomy	Phase 4
Completed	`NCT00873054` - Percutaneous Nephrolithotomy Versus Extracorporeal Shock Wave Lithotripsy	N/A
Withdrawn	`NCT00583258` - A Randomized Study of Whether Alfuzosin(Xatral) Helps in the Passage of Kidney Stones	N/A
Active, not recruiting	`NCT03630926` - Evaluation of the NV-VPAC1 Prostate Cancer (PCa) Urine Diagnostic Test in Subjects With Biopsy-confirmed Prostate Cancer, Benign Prostatic Hypertrophy, or Bladder/Kidney Stones.
Not yet recruiting	`NCT02214836` - Ultrasound Imaging of Kidney Stones and Lithotripsy	N/A
Completed	`NCT03095885` - A Pilot Study of Oxalate Absorption in Secondary Hyperoxaluria	N/A
Completed	`NCT01088555` - Effect of Sodium Thiosulfate on Urine Chemistries of Hypercalciuric Stone Formers	N/A
Completed	`NCT01330940` - Effect of Diet Orange Soda on Urinary Lithogenicity	N/A
Recruiting	`NCT00489723` - Is There is a Role of Prophylactic Therapy With Tamsulosin Before Extracorporeal Shock Wave Lithotripsy to Avoid Development of Steinstrasse ?	N/A
Recruiting	`NCT05417568` - Oxalate-Driven Host Responses in Kidney Stone Disease	N/A
Recruiting	`NCT02375295` - Struvite Stones Antibiotic Study	Phase 4
Enrolling by invitation	`NCT02408211` - Preoperative Antibiotic PNL Study	Phase 4
Withdrawn	`NCT01560091` - Differential Effect of Silodosin Versus Tamsulosin on Stone Clearance After Extra-corporeal Shock Wave Lithotripsy	Phase 3
Completed	`NCT00857090` - Pharmacokinetic, Safety and Efficacy Study of OMS201 in Subjects Undergoing Retrograde Ureteroscopic Removal of Upper Urinary Tract Stones	Phase 1/Phase 2